Treatment for Vitamin B12 Deficiency Symptoms
For symptomatic vitamin B12 deficiency, treatment should include 1000-2000 μg daily sublingual or intramuscular (IM) injections, or 1000 mcg intramuscularly every month to prevent irreversible neurological damage. 1
Diagnosis Confirmation
Before initiating treatment, confirm B12 deficiency with appropriate testing:
Initial testing should use either:
- Total B12 (serum cobalamin) or
- Active B12 (serum holotranscobalamin)
Interpret results according to these thresholds:
- Confirmed deficiency: Total B12 <180 ng/L or active B12 <25 pmol/L
- Indeterminate: Total B12 180-350 ng/L or active B12 25-70 pmol/L
- Unlikely deficiency: Total B12 >350 ng/L or active B12 >70 pmol/L 1
For indeterminate results, measure serum methylmalonic acid (MMA) to confirm deficiency
Additional helpful tests: homocysteine, complete blood count, and folate levels 1
Treatment Protocol
Immediate Treatment
Severe deficiency or neurological symptoms: Intramuscular (IM) administration is preferred for rapid improvement 2, 3
- Initial loading dose followed by maintenance therapy
- Prevents permanent degenerative lesions of the spinal cord that may develop if deficiency progresses beyond 3 months 4
Mild to moderate deficiency without severe neurological symptoms:
Treatment Based on Cause
Malabsorption-related deficiency (pernicious anemia, gastrointestinal pathology, post-gastrectomy):
Dietary deficiency (vegans, vegetarians):
Post-bariatric surgery:
Crohn's disease with ileal involvement/resection:
- 1000 μg of vitamin B12 monthly if >20 cm of distal ileum is resected 1
Medication-induced deficiency (metformin, PPIs, H2 blockers):
- Oral supplementation while continuing necessary medications 3
Monitoring Response to Treatment
- Expect improvement in fatigue within weeks of starting treatment
- Hematologic response should show improvement within 4 weeks 1
- Monitor:
Important Cautions
- Warning: Folic acid supplementation >0.1 mg/day may mask B12 deficiency by improving hematologic symptoms while allowing neurological damage to progress 4
- Treatment must continue long-term for conditions with permanent malabsorption
- Discontinuing treatment in pernicious anemia will result in return of anemia and irreversible nerve damage 4
- "Titration" of injection frequency based solely on biomarkers is not recommended; treatment should be guided by symptom resolution 2
Special Populations
- Pregnant/lactating women: Require increased intake (4 mcg daily) 4
- Elderly patients (>75 years): Higher risk due to age-related decline in absorption capacity and higher prevalence of atrophic gastritis 1
- Children: Intake should be 0.5 to 3 mcg daily as recommended by the Food and Nutrition Board 4
Early diagnosis and prompt treatment are essential to prevent irreversible neurological complications of vitamin B12 deficiency 1, 2.